Voyager Therapeutics, Inc. Share Price

Voyager Therapeutics, Inc. Share Price

NASDAQ: VYGR | Micro Cap
$1.52
-$0.10 (-6.17%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Voyager Therapeutics, Inc. Stock Performance

Open
$1.62
Prev. Close
$1.62
Circuit Range
N/A
Day Range
$1.50 - $1.67
Year Range
$1.50 - $5.42
Volume
74,144
Average Traded
$1.60

Voyager Therapeutics, Inc. Share Price Today

As of 18 November 2026, Voyager Therapeutics, Inc.'s share price is $1.52. The stock opened at $1.62, compared to its previous close of $1.62. During today's trading session, Voyager Therapeutics, Inc.'s share price traded between $1.50 and $1.67, with an average price of $1.59. Over the past 52 weeks, the stock has recorded a high of $5.42 and a low of $1.50. In terms of performance, Voyager Therapeutics, Inc.'s share price has declined by 60.72% over the last six months and is down 62.79% on a year-on-year basis.

Voyager Therapeutics, Inc. Share Price Chart

Line chart of the Voyager Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 1.50 to 1.67, ending at 1.52.
$1.50$1.67
L
Show Current Price
H

Voyager Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$89.21M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.68
Revenue (TTM)
$40.37B
Return On Equity (TTM)
-77.58%
Profit Margin
-296.56%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
9.99%

Voyager Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$15.34$2.59$3.17$4.01
Net Profit-$27.43-$28.23-$24.47-$24.69
Net Profit Margin-178.81%-1089.96%-771.92%-615.71%
Income ChangeN/A-2.92%13.32%-0.90%

Voyager Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$40.91$250.01$80.00$40.37
Net Profit-$46.41$132.33-$65.00-$119.72
Net Profit Margin-113.44%52.93%-81.25%-296.56%
Income ChangeN/A385.13%-149.12%-84.18%

About Voyager Therapeutics, Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Voyager Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.77
$1.53
-11.30%
Oct 2026
$2.65
$1.73
-35.99%
Sep 2026
$3.44
$2.69
-22.00%
Aug 2026
$3.08
$3.46
+14.03%
Jul 2026
$3.55
$3.03
-13.18%
Jun 2026
$3.85
$3.49
-9.82%
May 2026
$3.71
$3.87
+3.75%
Apr 2026
$3.91
$3.73
-3.49%
Mar 2026
$4.05
$3.87
-5.96%
Feb 2026
$3.91
$4.11
+5.12%
Jan 2026
$3.87
$3.91
-0.51%
Dec 2025
$3.95
$3.93
-3.79%

VYGR Share Price FAQs